Dr Piao Xijun
Vice President
Head of mRNA Process Development
CATUG Biotechnology, China
Important decisions for mRNA Vaccines and Therapeutics Development
Thursday, 15th June 2023
13:00 - 14:30 (GMT +8)
View other Time Zones
mRNA vaccines and therapeutics are gaining attention for their potential in treating diseases as it hold immense promise in the field of medicine. The manufacturing process involves key steps such as mRNA synthesis, lipid nanoparticle (LNP) formulation, and overcoming challenges in Chemistry, Manufacturing, and Controls (CMC). Developing a comprehensive understanding of the end-to-end manufacturing process, addressing key challenges in mRNA and LNPs process development, and implementing effective GMP manufacturing strategies are crucial for the successful translation of mRNA-based therapies into clinical practice.
Join our webinar on the 15th June to hear from the experts as they take us on a deep dive into understanding this new technology and the potential it holds.
*This webinar will be delivered in English and simultaneous interpretation is available in Japanese, Korean and Mandarin
Who should attend:
- Participants include C-suites, Head of departments, Professors, Clinicians, Lab directors, Lab managers, Post Doctoral researchers, Lab technicians, Students, or any professionals interested in understanding in mRNA vaccines and therapeutics development
Key reasons to attend:
- General overview of the mRNA vaccines and therapeutics development
- Overview of end-to-end manufacturing process for mRNA modality.
- Key points of mRNA & LNP process development.
- Major challenges for early CMC work.
- Case study for mRNA & LNP PD and GMP manufacturing
Faculty
Speaker |
|
SpeakerDr Piao XijunVice President in CATUG Biotechnology |
Dr. Piao is currently Vice President in CATUG Biotechnology, responsible for mRNA & LNP research, process development, scale-up, and tech transfer. Prior to CATUG, he worked in Ultragenyx Pharmaceutical Inc with increasing responsibilities from building mRNA platform to CMC DS lead. Dr. Piao has over 12 years research and process development experience in nucleic acid
Speaker |
Dr Rena AkahoriScientist |
|
SpeakerDr Rena AkahoriScientist, Chemistry, Manufacturing and Controls (CMC) Development Group |
Dr. Akahori is currently a scientist of CMC development group in ARCALIS Inc., responsible for mRNA research, especially investigations of mRNA production method and its characterization. Prior to ARCALIS, she worked in Research and Development group of Hitachi ltd., with responsibilities for development of next- generation Nanopore DNA sequencers. Dr. Akahori has over 13 years research experience in nucleic acid.
Speaker |
Dr Bhawana Poudel-BochmannInternational Product Manager, mRNA Product Portfolio, Roche Diagnostics,Germany |
|
Dr Bhawana Poudel-BochmannInternational Product Manager, mRNA Product Portfolio, Roche Diagnostics |
Dr Bhawana is International Product Manager responsible for mRNA product portfolio of CustomBiotech business. Prior to joining Roche, Bhawana held various positions in sales and global marketing at QIAGEN GmbH, Germany. Bhawana holds a PhD in Cardiovascular disease from Imperial College London and a Bachelor’s degree in Biochemistry and Cell Biology from Jacobs University Bremen, Germany.
Moderator |
Mr Cao De JunMarketing Lead CustomBiotech - Life Science |
|
ModeratorMr Cao De JunMarketing Lead (CustomBiotech) |
Cao De Jun presently holds the position of Marketing Lead at Roche Diagnostics (China) in the Life Sciences CustomBiotech division. He earned a master's degree in cell biology from Peking Union Medical College. Throughout his career, Mr. Cao has held various roles in sales, marketing, and technical management within renowned multinational companies. He possesses in-depth knowledge of scientific research, biopharmaceuticals, clinical diagnosis, and other markets, and has extensive experience in product development and marketing.
Live Webinar Date & Time
 |
Date:15th June 2023 at 13:00-14:30 (GMT+8) |
 |
|